Peptone
7 known investors
Peptone develops a product engine to design small-molecule drug candidates targeting intrinsically disordered proteins, which have been difficult to address with conventional drug discovery approaches.
Investors · 7
Bessemer Venture Partners✓ verifiedRedwood City · $5M – $100M
Hoxton Ventures✓ verifiedLondon · $500K – $5M
F-Prime Capital✓ verified
Walden Catalyst✓ verifiedSan Francisco · $550K
F-Prime Capital PartnersCambridge · $3M – $10M
Founders FactoryLondon · $150K – $200K
Novartis Venture FundreportedBasel · $5M – $25M
In the news
- Peptone Market to Reach $240.5 million, Globally, by 2035 at 4.2% CAGR: Allied Market Researchglobenewswire.com · 2025
- London-based Peptone raises €38.29M to help discover drugs for tricky ‘disordered’ proteins - Silicon Canalssiliconcanals.com · 2022
- Peptone closes a $40M Series-A funding round led by F-Prime and Bessemer Venture Partnerspeptone.io · 2022
- Startup Peptone raises $40 million in venture funding to find drugs for tricky 'disordered' proteins using A.I. | Fortune Europefortune.com · 2022
- Peptone 6/9/2022 Capital Raise - Gaebler.com Venture Capital Databasegaebler.com